TCG's R&D venture team makes a T cell engager deal with Shanghai biotech
The Column Group's drug R&D team, known as TCG Labs Soleil, has been busy churning out new portfolio companies since it unveiled with a $400 million-plus fund in February. And on Tuesday ...
The Column Group's drug R&D team, known as TCG Labs Soleil, has been busy churning out new portfolio companies since it unveiled with a $400 million-plus fund in February.
And on Tuesday ...
